Discover 833 paid clinical trials in Alberta . Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 833
HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs
for
Degenerative Disc Disease (DDD)
Location: Richmond VA, West Palm Beach FL, Port Charlotte FL,
Sponsor: ReGelTec, Inc.
Sex: All
Age: 22 - 70+
Code: NCT06011551
Recruiting
Intra-articular Hyaluronic Acid Injection for Therapy-resistant Patellofemoral Pain Syndrome
for
Patellofemoral Pain Syndrome
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 18 - 45
Code: NCT02613247
Phase2, Recruiting
Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL)
for
Relapsed Non Hodgkin Lymphoma, Relapsed Adult ALL,
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 2 - 70
Code: NCT03938987
Phase1, Phase2, Recruiting
Intravenous Immunoglobulin (IVIG) for Resistant Neuropathic Pain
for
Neuropathic Pain
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 18+
Code: NCT00850005
Phase2, Recruiting
Frameless Stereotactic Radiosurgery for Brain Metastases
for
Brain Metastases
Location: Calgary
Sponsor: Alberta Health services
Sex: All
Age: 18+
Code: NCT01476878
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
for
Heart Failure, Acute Heart Failure
Location: Boston MA, Providence RI, Stony Brook NY, Sherbrooke,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06008197
Phase3, Recruiting
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
A Study of Genetic Based Chemotherapy Dosing for Breast Cancer Patients
for
Breast Neoplasms
Location: Edmonton
Sponsor: AHS Cancer Control Alberta
Sex: Female
Age: 18+
Code: NCT01740271
Phase2, Recruiting
Pompe Disease Registry Protocol
for
Glycogen Storage Disease Type II, Pompe Disease
Location: Moncton, Portland ME, Boston MA, Springfield MA,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00231400
Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
for
Fabry Disease
Location: St. John's, Halifax, Moncton, Portland ME, Boston MA,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00196742
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
for
Gaucher Disease, Cerebroside Lipidosis Syndrome,
Location: Moncton, Portland ME, Boston MA, New Haven CT,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00358943
Recruiting
Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma
for
Sarcoma
Location: St. John's, Halifax, Boston MA, Quebec, Bronx NY,
Sponsor: University of Leicester
Sex: All
Age: 0 - 49
Code: NCT00020566
Phase3, Recruiting
Product Surveillance Registry
for
Cardiac Rhythm Disorders, Urological Disorders,
Location: Boston MA, Riverhead NY, Hartford CT, Holyoke MA,